2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 3
1
Status
Completed
2
Recruiting
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Breast
2
Head & Neck
1
Conditions
Neuralgia
1
Head and Neck Neoplasms
1
Breast Neoplasms
1
Breast Cancer Patient
1
Agnosia
1
Interventions
Specimen Handling
629
pembrolizumab
559
Magnetic Resonance Spectroscopy
539
Carboplatin
423
Cyclophosphamide
371
Cisplatin
371
Biopsy
357
Paclitaxel
304
Nivolumab
301
Gemcitabine
299
Radiotherapy
270
Bevacizumab
238
Dexamethasone
207
fludarabine
205
Docetaxel
189
durvalumab
178
atezolizumab
176
Oxaliplatin
172
Fluorouracil
167
venetoclax
164
Rituximab
164
Pemetrexed
162
Radiation
159
Doxorubicin
159
Capecitabine
158
Radiosurgery
147
Etoposide
137
Ipilimumab
134
Leucovorin
133
Lenalidomide
130
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Capsaicin
×
90 days
×
Clear all
NCT03794388
2026-05-05
CAPTRANE
Institut Cancerologie de l'Ouest
Phase 3
Completed
140 enrolled
6 charts
NCT04704453
2026-04-14
TEC-ORL
Institut Claudius Regaud
Phase 2
Completed
13 enrolled
NCT06807164
2026-03-27
SerCaBot
Centre Oscar Lambret
Phase 2
Recruiting
123 enrolled